ArticleScientific reports2025
pSOFA score serves as predicting the severity and outcome of sepsis in critically ill children.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- An explainable machine learning model for early pediatric sepsis prediction using cytokine and routine laboratory data.Pediatric research · 2026Article
- Comparison of Phoenix Sepsis Score and traditional scoring systems in predicting mortality in PICU patients with suspected infection.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
To investigate the prognostic value of the Pediatric Sequential Organ Failure Assessment (pSOFA) in children with sepsis during hospitalization. Clinical data for children with sepsis or severe sepsis hospitalized in the PICU of the First Affiliated Hospital of Sun Yat-Sen University and that of Shenzhen Children’s Hospital from December 2014 to December 2019 were retrospectively analyzed. Spearman correlation analysis was used to compare correlations among pSOFA, PRISM III, PELOD-2 and P-MODS. Receiver operating characteristic (ROC) curves were plotted to evaluate the efficacy of pSOFA, Pediatric risk of mortality Ⅲ (PRISM III), pediatric logistic organ dysfunction-2 (PELOD-2), and pediatric multiple organ dysfunction score (P-MODS) in predicting risk of death from childhood sepsis based on the area under the ROC curve (AUC). A total of 456 eligible pediatric patients were ultimately enrolled. The median age was 21 months, the mortality rate was 24.1%, and the average length of hospital stay in the PICU was 9 days. Spearman correlation analysis showed the best correlation between pSOFA and PELOD-2 scores (R = 0.554, P < 0.001), followed by PRISM III (R = 0.474, P < 0.001) and P-MODS (R = 0.466, P < 0.001). Based on ROC curve analysis, the AUCs of pSOFA, PRISM III, PELOD-2 and P-MODS for predicting mortality risk were 0.85 (95% CI, 0.81–0.88, P < 0.001), 0.80 (95% CI, 0.76–0.84, P < 0.001), 0.78 (95% CI, 0.74–0.82, P < 0.001) and 0.72 (95% CI, 0.67–0.76, P < 0.001), respectively. The best cutoff value of pSOFA for predicting in-hospital death in children with sepsis was > 7 (sensitivity 88.07%, specificity 64.71%). Moreover, the Hosmer–Lemeshow goodness-of-fit test indicated better calibration between predicted mortality and observed mortality for pSOFA PRISM III and PELOD-2 (pSOFA: P=0.366;PRISM III༚P༝0.189༛PELOD-2༚P༝0.121), whereas P-MODS showed poor calibration (P<0.001). The AUC value of pSOFA was the highest, and its is superior to PRISM III and PELOD-2 scores at predicting the severity and prognosis of sepsis in children. pSOFA showed the best calibration between predicted mortality and observed mortality in childhood sepsis, followed by PRISM III and PELOD-2. Therefore, pSOFA has important guiding value in predicting risk of death from sepsis in children.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.